mr EDWARD BAXTER

Support H.R. 2985 - The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.

General issues related to prescription drug safety and the importation of prescription drugs. General issues regarding implementation of Public Law 111-148, Patient Protection and Affordable Care Act (ACT). Support H.R. 2985, the Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.

Support H.R. 2985, the Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.

Support H.R. 2985 - The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.

Support H.R. 2985 - The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.

General issues related to prescription drug safety and the importation of prescription drugs. General issues regarding implementation of Public Law 111-148, Patient Protection and Affordable Care Act. Support H.R. 2985, the Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.

Support H.R. 2985, the Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.

Support H.R. 2985 - The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.

S. 1347, The Conference Accountability Act of 2013. Legislation related to federal travel and attendance by federal employees at meetings and conventions, and to information required to be posted on federal websites related to government sponsored conferences.H.R. 313, Government Spending Accountability Act of 2013. Legislation related to federal travel and attendance by federal employees at meetings and conventions, and to information required to be posted on federal websites related to government sponsored conferences. H.R. 2696, legislation to increase transparency of agencies by requiring a report describing any proposed conferences.

S. 1347, The Conference Accountability Act of 2013. Legislation related to federal travel and attendance by federal employees at meetings and conventions, and to information required to be posted on federal websites related to government sponsored conferences. H.R. 313, Government Spending Accountability Act of 2013. Legislation related to federal travel and attendance by federal employees at meetings and conventions, and to information required to be posted on federal websites related to government sponsored conferences. H.R. 2696, legislation to increase transparency of agencies by requiring a report describing any proposed conference.

H.R. 4260, Ryan White Patient Equity and Choice Act

Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.

Monitored consideration of patent legislation; S. 1013, the patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.

Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.

Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.

H.R. 2052 / S. 1023, Global Investment in American Jobs Act of 2013

H.R. 2052 / S. 1023, Global Investment in American Jobs Act of 2013.

Monitored and opposed legislation affecting U.S. currency; specifically provisions which sought to eliminate the dollar bill and expand the circulation of dollar coins -- S. 1105, Currency Optimization, Innovation, and National Savings Act.

Monitored and opposed legislation affecting U.S. currency; specifically provisions which sought to eliminate the dollar bill and expand the circulation of dollar coins -- S. 1105, Currency Optimization, Innovation, and National Savings Act.

Monitored and opposed legislation affecting U.S. currency; specifically provisions which sought to eliminate the dollar bill and expand the circulation of dollar coins -- S. 1105, Currency Optimization, Innovation, and National Savings Act.

S. 1347, The Conference Accountability Act of 2013. Legislation related to federal travel and attendance by federal employees at meetings and conventions, and to information required to be posted on federal websites related to government sponsored conferences. H.R. 313, Government Spending Accountability Act of 2013. Legislation related to federal travel and attendance by federal employees at meetings and conventions, and to information required to be posted on federal websites related to government sponsored conferences. H.R. 2696, legislation to increase transparency of agencies by requiring a report describing any proposed conference.

S. 1347, The Conference Accountability Act of 2013. Legislation related to federal travel and attendance by federal employees at meetings and conventions, and to information required to be posted on federal websites related to government sponsored conferences.H.R. 313, Government Spending Accountability Act of 2013. Legislation related to federal travel and attendance by federal employees at meetings and conventions, and to information required to be posted on federal websites related to government sponsored conferences. H.R. 2696, legislation to increase transparency of agencies by requiring a report describing any proposed conferences.

Support reauthorization of PEPFAR (President's Emergency Plan for AIDS Relief), S. 1545. Support requirements that mandate a minimum percentage of funds that must be used for medical treatment. Support limiting spending per patient in order to treat more patients.Appropriations for State and Foreign Operations 2015. Support funding for PEPFAR (President's Emergency Plan for AIDS Relief). Support requirements that mandate a minimum percentage of funds that must be used for medical treatment. Support limiting spending per patient in order to treat more patients.

Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.

Monitored consideration of patent legislation; S. 1013, the patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.

Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.

Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.

Monitored and opposed legislation affecting U.S. currency -- specifically legislation similar to H.R. 2977/S. 2049, Currency Optimization, Innovation, and National Savings Act; which sought to eliminate the dollar bill and expand the circulation of dollar coins (introduced in the 112th Congress). No specific legislation has been introduced this Congress (113th).

Monitored and opposed legislation affecting U.S. currency -- specifically legislation similar to H.R. 2977/S. 2049, Currency Optimization, Innovation, and National Savings Act; which sought to eliminate the dollar bill and expand the circulation of dollar coins (introduced in the 112th Congress). No specific legislation has been introduced this Congress (113th).

H.R. 2052 / S. 1023, Global Investment in American Jobs Act of 2013.

H.R. 2052 / S. 1023, Global Investment in American Jobs Act of 2013.

S. 1347, The Conference Accountability Act of 2013. Legislation related to federal travel and attendance by federal employees at meetings and conventions, and to information required to be posted on federal websites related to government sponsored conferences.H.R. 313, Government Spending Accountability Act of 2013. Legislation related to federal travel and attendance by federal employees at meetings and conventions, and to information required to be posted on federal websites related to government sponsored conferences. H.R. 2696, legislation to increase transparency of agencies by requiring a report describing any proposed conferences.

S. 1347, The Conference Accountability Act of 2013. Legislation related to federal travel and attendance by federal employees at meetings and conventions, and to information required to be posted on federal websites related to government sponsored conferences.H.R. 313, Government Spending Accountability Act of 2013. Legislation related to federal travel and attendance by federal employees at meetings and conventions, and to information required to be posted on federal websites related to government sponsored conferences. H.R. 2696, legislation to increase transparency of agencies by requiring a report describing any proposed conferences.

Support H.R. 2985 - The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.

General issues related to prescription drug safety and the importation of prescription drugs. General issues regarding implementation of Public Law 111-148, Patient Protection and Affordable Care Act.Issues related to School Access to Emergency Epinephrine. Support H.R. 2985, the Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.

Support H.R. 2985 - The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.

Support H.R. 2985, the Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.

Support H.R. 2985 - The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.

Support H.R. 2985 - The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.

General issues related to prescription drug safety and the importation of prescription drugs. General issues regarding implementation of Public Law 111-148, Patient Protection and Affordable Care Act. Support H.R. 2985, the Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.

Support H.R. 2985, the Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.

S. 1347, The Conference Accountability Act of 2013. Legislation related to federal travel and attendance by federal employees at meetings and conventions, and to information required to be posted on federal websites related to government sponsored conferences.H.R. 313, Government Spending Accountability Act of 2013. Legislation related to federal travel and attendance by federal employees at meetings and conventions, and to information required to be posted on federal websites related to government sponsored conferences. H.R. 2696, legislation to increase transparency of agencies by requiring a report describing any proposed conferences.

S. 1347, The Conference Accountability Act of 2013. Legislation related to federal travel and attendance by federal employees at meetings and conventions, and to information required to be posted on federal websites related to government sponsored conferences.H.R. 313, Government Spending Accountability Act of 2013. Legislation related to federal travel and attendance by federal employees at meetings and conventions, and to information required to be posted on federal websites related to government sponsored conferences. H.R. 2696, legislation to increase transparency of agencies by requiring a report describing any proposed conferences.

Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.

Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.

H.R. 2052 / S. 1023, Global Investment in American Jobs Act of 2013.

H.R. 2052 / S. 1023, Global Investment in American Jobs Act of 2013.

S. 1347, The Conference Accountability Act of 2013. Legislation related to federal travel and attendance by federal employees at meetings and conventions, and to information required to be posted on federal websites related to government sponsored conferences.H.R. 313, Government Spending Accountability Act of 2013. Legislation related to federal travel and attendance by federal employees at meetings and conventions, and to information required to be posted on federal websites related to government sponsored conferences. H.R. 2696, legislation to increase transparency of agencies by requiring a report describing any proposed conferences.

S. 1347, The Conference Accountability Act of 2013. Legislation related to federal travel and attendance by federal employees at meetings and conventions, and to information required to be posted on federal websites related to government sponsored conferences.H.R. 313, Government Spending Accountability Act of 2013. Legislation related to federal travel and attendance by federal employees at meetings and conventions, and to information required to be posted on federal websites related to government sponsored conferences. H.R. 2696, legislation to increase transparency of agencies by requiring a report describing any proposed conferences.

Support reauthorization of PEPFAR (President's Emergency Plan for AIDS Relief), S. 1545. Support requirements that mandate a minimum percentage of funds that must be used for medical treatment. Support limiting spending per patient in order to treat more patients.Appropriations for State and Foreign Operations 2014. Support funding for PEPFAR (President's Emergency Plan for AIDS Relief), S. 1545. Support requirements that mandate a minimum percentage of funds that must be used for medical treatment. Support limiting spending per patient in order to treat more patients.

Support reauthorization of PEPFAR (President's Emergency Plan for AIDS Relief), S. 1545. Support requirements that mandate a minimum percentage of funds that must be used for medical treatment. Support limiting spending per patient in order to treat more patients.Appropriations for State and Foreign Operations 2014. Support funding for PEPFAR (President's Emergency Plan for AIDS Relief). Support requirements that mandate a minimum percentage of funds that must be used for medical treatment. Support limiting spending per patient in order to treat more patients.

Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.

Monitored consideration of patent legislation; S. 1013, the Patent Abuse Reduction Act of 2013; S. 1612, Patent Litigation Integrity Act of 2013; and H.R. 3309, the Innovation Act.

Monitored and opposed legislation affecting U.S. currency -- specifically legislation similar to H.R. 2977/S. 2049, Currency Optimization, Innovation, and National Savings Act; which sought to eliminate the dollar bill and expand the circulation of dollar coins (introduced in the 112th Congress). No specific legislation has been introduced this Congress (113th).

Monitored and opposed legislation affecting U.S. currency -- specifically legislation similar to H.R. 2977/S. 2049, Currency Optimization, Innovation, and National Savings Act; which sought to eliminate the dollar bill and expand the circulation of dollar coins (introduced in the 112th Congress). No specific legislation has been introduced this Congress (113th).

Monitored and opposed legislation affecting U.S. currency -- specifically legislation similar to H.R. 2977/S. 2049, Currency Optimization, Innovation, and National Savings Act; which sought to eliminate the dollar bill and expand the circulation of dollar coins (introduced in the 112th Congress). No specific legislation has been introduced this Congress (113th).

Monitored and opposed legislation affecting U.S. currency -- specifically legislation similar to H.R. 2977/S. 2049, Currency Optimization, Innovation, and National Savings Act; which sought to eliminate the dollar bill and expand the circulation of dollar coins (introduced in the 112th Congress). No specific legislation has been introduced this Congress (113th).

Opposed efforts to preclude settlements in patent litigation. S. 214, Preserve Access to Affordable Generics Act

Oppose bills that prohibit brand name drug companies from settling patent litigation with generic drug companies and for other purposes. S. 214, Preserve Access to Affordable Generics Act.

Opposed efforts to preclude settlements in patent litigation. S. 214, Preserve Access to Affordable Generics Act

Opposed efforts to preclude settlements in patent litigation. S. 214, Preserve Access to Affordable Generics Act

Oppose bills that prohibit brand name drug companies from settling patent litigation with generic drug companies and for other purposes. S. 214, Preserve Access to Affordable Generics Act.

Monitored and opposed legislation affecting U.S. currency -- specifically legislation similar to H.R. 2977/S. 2049, Currency Optimization, Innovation, and National Savings Act; which sought to eliminate the dollar bill and expand the circulation of dollar coins (introduced in the 112th Congress). No specific legislation has been introduced this Congress (113th).

Monitored and opposed legislation affecting U.S. currency -- specifically legislation similar to H.R. 2977/S. 2049, Currency Optimization, Innovation, and National Savings Act; which sought to eliminate the dollar bill and expand the circulation of dollar coins (introduced in the 112th Congress). No specific legislation has been introduced this Congress (113th).

Monitored and opposed legislation affecting U.S. currency -- specifically legislation similar to H.R. 2977/S. 2049, Currency Optimization, Innovation, and National Savings Act; which sought to eliminate the dollar bill and expand the circulation of dollar coins (introduced in the 112th Congress). No specific legislation has been introduced this Congress (113th).

Monitored and opposed legislation affecting U.S. currency -- specifically legislation similar to H.R. 2977/S. 2049, Currency Optimization, Innovation, and National Savings Act; which sought to eliminate the dollar bill and expand the circulation of dollar coins (introduced in the 112th Congress). No specific legislation has been introduced this Congress (113th).

Medicare Part D reimbursement issues dealing with patient payments in the "doughnut hole." No legislation introduced. Monitor PDUFA (Prescription Drug User Fee Act) reauthorization under S. 3187, Food and Drug Administration Safety and Innovation Act.

FDA reform and legislation related to dietary supplements. S. 216, Food Safety Accountability Act of 2011, to increase criminal penalties for certain knowing and intentional violations relating to food that is misbranded or adulterated. Monitor development of regulations by the FDA that overly restrict the dietary supplement industry. Support language in Agriculture Appropriations Act (H.R. 5973) to restrict scope of FDA regulations concerning dietary supplements. H.R. 1364, Free Speech About Science Act of 2011. Legislation to allow growers of healthy foods and manufacturers of dietary supplements to cite legitimate scientific studies on the health benefits of these products without having them classified as unapproved new drugs. S. 1098/H.R. 2010, the Family Retirement and Health Investment Act, increasing limits of and making improvements to Health Savings Accounts, and allowing for dietary supplements to be included as qualified medical costs. Monitor development of regulations by the FDA that overly restrict the dietary supplement industry. No specific legislation yet. Oppose legislation to amend the Controlled Substances Act to prevent the alleged abuse of dehydroepiandrosterone. FDA authority and regulation of dietary supplements, specifically with regards to a current DOD initiative/review of products containing DMAA. No legislation is applicable or expected. H.R. 6584, Verifying Authority and Legality In Drug Compounding Act of 2012. H.R. 6638, S.A.F.E. Compounded Drugs Act of 2012.

FDA reform and legislation related to dietary supplements. S. 216, Food Safety Accountability Act of 2011, to increase criminal penalties for certain knowing and intentional violations relating to food that is misbranded or adulterated. S. 1310, Dietary Supplement Labeling Act. H.R. 1364, Free Speech About Science Act. Legislation to allow growers of healthy foods and manufacturers of dietary supplements to cite legitimate scientific studies on the health benefits of these products without having them classified as unapproved new drugs.

FDA reform and legislation related to dietary supplements. S. 216, Food Safety Accountability Act of 2011, to increase criminal penalties for certain knowing and intentional violations relating to food that is misbranded or adulterated. S. 1310, Dietary Supplement Labeling Act. H.R. 1364, Free Speech About Science Act. Legislation to allow growers of healthy foods and manufacturers of dietary supplements to cite legitimate scientific studies on the health benefits of these products without having them classified as unapproved new drugs. H.R. 5973, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. Contains language that restricts judicial review of genetically modified organisms (GMOs). H.R. 6083, Federal Agriculture Reform and Risk Management Act of 2012. Contains provisions affecting genetically modified organisms (GMOs).

FDA reform and legislation related to dietary supplements. S. 216, Food Safety Accountability Act of 2011, to increase criminal penalties for certain knowing and intentional violations relating to food that is misbranded or adulterated. S. 1310, Dietary Supplement Labeling Act. H.R. 1364, Free Speech About Science Act. Legislation to allow growers of healthy foods and manufacturers of dietary supplements to cite legitimate scientific studies on the health benefits of these products without having them classified as unapproved new drugs.

FDA reform and legislation related to dietary supplements. S. 216, Food Safety Accountability Act of 2011, to increase criminal penalties for certain knowing and intentional violations relating to food that is misbranded or adulterated. Monitor development of regulations by the FDA that overly restrict the dietary supplement industry. Support language in Agriculture Appropriations Act (H.R. 5973) to restrict scope of FDA regulations concerning dietary supplements. H.R. 1364, Free Speech About Science Act of 2011. Legislation to allow growers of healthy foods and manufacturers of dietary supplements to cite legitimate scientific studies on the health benefits of these products without having them classified as unapproved new drugs. S. 1098/H.R. 2010, the Family Retirement and Health Investment Act, increasing limits of and making improvements to Health Savings Accounts, and allowing for dietary supplements to be included as qualified medical costs. Monitor development of regulations by the FDA that overly restrict the dietary supplement industry. No specific legislation yet. Oppose legislation to amend the Controlled Substances Act to prevent the alleged abuse of dehydroepiandrosterone. FDA authority and regulation of dietary supplements, specifically with regards to a current DOD initiative/review of products containing DMAA. No legislation is applicable or expected.

FDA reform and legislation related to dietary supplements. S. 216, Food Safety Accountability Act of 2011, to increase criminal penalties for certain knowing and intentional violations relating to food that is misbranded or adulterated. Monitor development of regulations by the FDA that overly restrict the dietary supplement industry. Support language in Agriculture Appropriations Act (H.R. 5973) to restrict scope of FDA regulations concerning dietary supplements. H.R. 1364, Free Speech About Science Act of 2011. Legislation to allow growers of healthy foods and manufacturers of dietary supplements to cite legitimate scientific studies on the health benefits of these products without having them classified as unapproved new drugs. S. 1098/H.R. 2010, the Family Retirement and Health Investment Act, increasing limits of and making improvements to Health Savings Accounts, and allowing for dietary supplements to be included as qualified medical costs. Monitor development of regulations by the FDA that overly restrict the dietary supplement industry. No specific legislation yet. Oppose legislation to amend the Controlled Substances Act to prevent the alleged abuse of dehydroepiandrosterone. FDA authority and regulation of dietary supplements, specifically with regards to a current DOD initiative/review of products containing DMAA. No legislation is applicable or expected.

FDA reform and legislation related to dietary supplements. S. 216, Food Safety Accountability Act of 2011, to increase criminal penalties for certain knowing and intentional violations relating to food that is misbranded or adulterated. S. 1310, Dietary Supplement Labeling Act. H.R. 1364, Free Speech About Science Act. Legislation to allow growers of healthy foods and manufacturers of dietary supplements to cite legitimate scientific studies on the health benefits of these products without having them classified as unapproved new drugs. H.R. 5973, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. Contains language that restricts judicial review of genetically modified organisms (GMOs). H.R. 6083, Federal Agriculture Reform and Risk Management Act of 2012. Contains provisions affecting genetically modified organisms (GMOs).

FDA reform and legislation related to dietary supplements. S. 216, Food Safety Accountability Act of 2011, to increase criminal penalties for certain knowing and intentional violations relating to food that is misbranded or adulterated. H.R. 1364, Free Speech About Science Act of 2011. Legislation to allow growers of healthy foods and manufacturers of dietary supplements to cite legitimate scientific studies on the health benefits of these products without having them classified as unapproved new drugs. S. 1098/H.R. 2010, the Family Retirement and Health Investment Act, increasing limits of and making improvements to Health Savings Accounts, and allowing for dietary supplements to be included as qualified medical costs. Monitor development of regulations by the FDA that overly restrict the dietary supplement industry. Oppose legislation to amend the Controlled Substances Act to prevent the alleged abuse of dehydroepiandrosterone.

S. 1098/H.R. 2010, the Family Retirement and Health Investment Act, increasing limits of and making improvements to Health Savings Accounts, and allowing for dietary supplements to be included as qualified medical costs.

S. 1098/H.R. 2010, the Family Retirement and Health Investment Act, increasing limits of and making improvements to Health Savings Accounts, and allowing for dietary supplements to be included as qualified medical costs.

S. 1098/H.R. 2010, the Family Retirement and Health Investment Act, increasing limits of and making improvements to Health Savings Accounts, and allowing for dietary supplements to be included as qualified medical costs.

FDA reform and legislation related to dietary supplements. S. 216, Food Safety Accountability Act of 2011, to increase criminal penalties for certain knowing and intentional violations relating to food that is misbranded or adulterated. Monitor development of regulations by the FDA that overly restrict the dietary supplement industry. Support language in Agriculture Appropriations Act (H.R. 5973) to restrict scope of FDA regulations concerning dietary supplements. H.R. 1364, Free Speech About Science Act of 2011. Legislation to allow growers of healthy foods and manufacturers of dietary supplements to cite legitimate scientific studies on the health benefits of these products without having them classified as unapproved new drugs. S. 1098/H.R. 2010, the Family Retirement and Health Investment Act, increasing limits of and making improvements to Health Savings Accounts, and allowing for dietary supplements to be included as qualified medical costs. Monitor development of regulations by the FDA that overly restrict the dietary supplement industry. No specific legislation yet. Oppose legislation to amend the Controlled Substances Act to prevent the alleged abuse of dehydroepiandrosterone. FDA authority and regulation of dietary supplements, specifically with regards to a current DOD initiative/review of products containing DMAA. No legislation is applicable or expected.

Tax legislation that would reduce the tax treatment of charitable contributions. No specific legislation introduced. S. 1098/H.R. 2010, the Family Retirement and Health Investment Act, increasing limits of and making improvements to Health Savings Accounts. H.R. 605, Patients' Freedom to Choose Act, restoring recently enacted limitations to Health Savings Accounts and flexible spending plans.

S. 1098/H.R. 2010, the Family Retirement and Health Investment Act, increasing limits of and making improvements to Health Savings Accounts, and allowing for dietary supplements to be included as qualified medical costs.

FDA reform and legislation related to dietary supplements. S. 216, Food Safety Accountability Act of 2011, to increase criminal penalties for certain knowing and intentional violations relating to food that is misbranded or adulterated. Monitor development of regulations by the FDA that overly restrict the dietary supplement industry. Support language in Agriculture Appropriations Act (H.R. 5973) to restrict scope of FDA regulations concerning dietary supplements. H.R. 1364, Free Speech About Science Act of 2011. Legislation to allow growers of healthy foods and manufacturers of dietary supplements to cite legitimate scientific studies on the health benefits of these products without having them classified as unapproved new drugs. S. 1098/H.R. 2010, the Family Retirement and Health Investment Act, increasing limits of and making improvements to Health Savings Accounts, and allowing for dietary supplements to be included as qualified medical costs. Monitor development of regulations by the FDA that overly restrict the dietary supplement industry. No specific legislation yet. Oppose legislation to amend the Controlled Substances Act to prevent the alleged abuse of dehydroepiandrosterone. FDA authority and regulation of dietary supplements, specifically with regards to a current DOD initiative/review of products containing DMAA. No legislation is applicable or expected. H.R. 6584, Verifying Authority and Legality In Drug Compounding Act of 2012. H.R. 6638, S.A.F.E. Compounded Drugs Act of 2012.

FDA reform and legislation related to dietary supplements. S. 216, Food Safety Accountability Act of 2011, to increase criminal penalties for certain knowing and intentional violations relating to food that is misbranded or adulterated. Monitor development of regulations by the FDA that overly restrict the dietary supplement industry. Support language in Agriculture Appropriations Act (H.R. 5973) to restrict scope of FDA regulations concerning dietary supplements. H.R. 1364, Free Speech About Science Act of 2011. Legislation to allow growers of healthy foods and manufacturers of dietary supplements to cite legitimate scientific studies on the health benefits of these products without having them classified as unapproved new drugs. S. 1098/H.R. 2010, the Family Retirement and Health Investment Act, increasing limits of and making improvements to Health Savings Accounts, and allowing for dietary supplements to be included as qualified medical costs. Monitor development of regulations by the FDA that overly restrict the dietary supplement industry. No specific legislation yet. Oppose legislation to amend the Controlled Substances Act to prevent the alleged abuse of dehydroepiandrosterone. FDA authority and regulation of dietary supplements, specifically with regards to a current DOD initiative/review of products containing DMAA. No legislation is applicable or expected.

FDA reform and legislation related to dietary supplements. S. 216, Food Safety Accountability Act of 2011, to increase criminal penalties for certain knowing and intentional violations relating to food that is misbranded or adulterated. H.R. 1364, Free Speech About Science Act of 2011. Legislation to allow growers of healthy foods and manufacturers of dietary supplements to cite legitimate scientific studies on the health benefits of these products without having them classified as unapproved new drugs. S. 1098/H.R. 2010, the Family Retirement and Health Investment Act, increasing limits of and making improvements to Health Savings Accounts, and allowing for dietary supplements to be included as qualified medical costs. Monitor development of regulations by the FDA that overly restrict the dietary supplement industry. Oppose legislation to amend the Controlled Substances Act to prevent the alleged abuse of dehydroepiandrosterone.

Proposed executive order to limit the attendance of federal employees at widely attended events. Legislation that restricts the attendance of federal employees at meetings and conventions, and that affects meetings and conferences sponsored by non-governmental organizations. H.R. 2146, DATA Act; S. 1789, 21st Century Postal Service Act of 2012; and H.R. 4631, Government Spending Accountability Act of 2012.

Proposed executive order to limit the attendance of federal employees at widely attended events. Legislation that restricts the attendance of federal employees at meetings and conventions, and that affects meetings and conferences sponsored by non-governmental organizations. H.R. 2146, DATA Act and S. 1789, 21st Century Postal Service Act of 2012.

Proposed executive order to limit the attendance of federal employees at widely attended events. Legislation that restricts the attendance of federal employees at meetings and conventions, and that affects meetings and conferences sponsored by non-governmental organizations. H.R. 2146, DATA Act; S. 1789, 21st Century Postal Service Act of 2012; and H.R. 4631, Government Spending Accountability Act of 2012.

General issues related to prescription drug safety and the importation of prescription drugs. Opposed amendment to PDUFA, S. 3187, that would allow unsafe importation of drugs. General issues regarding implementation of Public Law 111-148, Patient Protection and Affordable Care Act - including issues related to the Independent Payment Advisory Board and efforts to repeal provisions that prohibit individuals from using Health Savings Accounts or Flexible Spending Accounts to purchase Over-The-Counter medical products, including such provisions in H.R.2529, Restoring Access to Medication Act and H.R.436 - Health Care Cost Reduction Act of 2012. Awareness and issues related to diabetes and patient access to diabetes care. H.R.4223, Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act of 2012 or "SAFE DOSES Act" - all provisions. Issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine. H.R. 2405 and S.1855, Pandemic and All Hazards Preparation Act Reauthorization of 2011 - all provisions. H.R. 3627 and S.1884, School Access to Emergency Epinephrine Act - all provisions. Education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues. Education and awareness of Dengue. All provisions of H. Res. 295, Promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with this disease.

General issues related to prescription drug safety and the importation of prescription drugs. Opposed amendment to PDUFA, S. 3187, that would allow unsafe importation of drugs. General issues regarding implementation of Public Law 111-148, Patient Protection and Affordable Care Act - including issues related to the Independent Payment Advisory Board. Issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine. H.R. 2405 and S.1855, Pandemic and All Hazards Preparation Act Reauthorization of 2011 - all provisions. H.R. 3627 and S.1884, School Access to Emergency Epinephrine Act - all provisions. Education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues. Education and awareness of Dengue. All provisions of H. Res. 295, Promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with this disease.

Monitored legislation affecting U.S. currency. Opposed H.R. 2977 - Currency Optimization, Innovation, and National Savings Act; which seeks to eliminate the dollar bill and expand the circulation of dollar coins.

Monitored legislation affecting U.S. currency. Opposed H.R. 2977 - Currency Optimization, Innovation, and National Savings Act; which seeks to eliminate the dollar bill and expand the circulation of dollar coins.

Monitored legislation affecting U.S. currency. Opposed H.R. 2977 - Currency Optimization, Innovation, and National Savings Act; which seeks to eliminate the dollar bill and expand the circulation of dollar coins.

Monitored legislation affecting U.S. currency. Opposed H.R. 2977 - Currency Optimization, Innovation, and National Savings Act; which seeks to eliminate the dollar bill and expand the circulation of dollar coins.

General issues related to prescription drug safety and the importation of prescription drugs. Opposed amendment to PDUFA, S. 3187, that would allow unsafe importation of drugs. General issues regarding implementation of Public Law 111-148, Patient Protection and Affordable Care Act - including issues related to the Independent Payment Advisory Board and efforts to repeal provisions that prohibit individuals from using Health Savings Accounts or Flexible Spending Accounts to purchase Over-The-Counter medical products, including such provisions in H.R.2529, Restoring Access to Medication Act and H.R.436 - Health Care Cost Reduction Act of 2012. Awareness and issues related to diabetes and patient access to diabetes care. H.R.4223, Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act of 2012 or "SAFE DOSES Act" - all provisions. Issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine. H.R. 2405 and S.1855, Pandemic and All Hazards Preparation Act Reauthorization of 2011 - all provisions. H.R. 3627 and S.1884, School Access to Emergency Epinephrine Act - all provisions. Education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues. Education and awareness of Dengue. All provisions of H. Res. 295, Promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with this disease.

Support H.R. 3627 and S. 1884, School Access to Emergency Epinephrine Act. General issues related to prescription drug safety and the importation of prescription drugs. Opposed amendment to PDUFA, S. 3187, that would allow unsafe importation of drugs.

General issues related to prescription drug safety and the importation of prescription drugs. Opposed amendment to PDUFA, S. 3187, that would allow unsafe importation of drugs. General issues regarding implementation of Public Law 111-148, Patient Protection and Affordable Care Act - including issues related to the Independent Payment Advisory Board. Issues related to the continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine. H.R. 2405 and S.1855, Pandemic and All Hazards Preparation Act Reauthorization of 2011 - all provisions. H.R. 3627 and S.1884, School Access to Emergency Epinephrine Act - all provisions. Education and awareness of influenza pandemic and biodefense funding in FY2012 and related international intellectual property issues. Education and awareness of Dengue. All provisions of H. Res. 295, Promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with this disease.